The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

3 CT images showed that the number of liver metastases had increased ... agents most widely used to treat metastatic neuroendocrine tumors. Our experience suggests that fluoropyrimidines and ...

Exelixis (NASDAQ:EXEL) said on Wednesday that the U.S. FDA has approved cabozantinib for patients 12 years of age and older ...

According to national cancer institute ... s ordeal began with a small, 2 cm neuroendocrine tumour in the rectum, which eventually spread to the liver, forming three additional tumours.

Surgery may be recommended even when the tumor has spread to other organs, such as the liver. However, for some types of neuroendocrine tumors, surgery may not be the optimal treatment. Our doctors ...

Histotripsy, a non-invasive procedure for liver cancer treatment, is now available in Metairie, offering hope to patients in a state with high liver cancer rates.

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

Liver resection is recommended to treat some types of cancer originating in the liver (hepatocellular cancer, bile duct cancer, and gallbladder cancer), and occasionally benign liver tumors that are ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer ...